Table 2.
Total sample n = 250 | Males n = 143 | Females n = 107 | |
---|---|---|---|
Control variables | |||
Male gender | -.19** | ||
Age (years) | .14* | .14 | .13 |
Education (years completed) | .11 | .09 | .16 |
African American | .14* | .12 | .17 |
Hispanic | -.13* | -.09 | -.19* |
Baseline Commitment to abstinence | .49*** | .53*** | .38*** |
Predictor variablesa | |||
No. of previous SUD treatment at intake | .04 | .13 | -.09 |
Mandated to index episode (yes) at intake | -.09 | -.10 | .03 |
Length of treatment stay (in days) | .17** | .11 | .17 |
Overall helpfulness of index episode | .24** | .20* | .27** |
Dependence severity (MINI) since baseline | -.15* | -.07 | -.25** |
Number of days drug problems past month | -.16* | -.10 | -.25* |
Cravings/temptation to use drugs | -.16* | -.15 | -.15 |
Perceived harm of future drug use | .43*** | .48*** | .33** |
Drug abstinence self-efficacy | .52*** | .51*** | .51*** |
Perceived stress | -.18** | -.20* | -20** |
Quality of life satisfaction | .32*** | .26** | .37*** |
Psychological ASI | .05 | .08 | -.07 |
Perceived social support for recovery | .36*** | .36*** | .38*** |
Number of network members in 12-step | .32*** | .33*** | .31** |
Number of 12-step meetings attended during treatment | .19** | .21* | .14 |
Level of involvement in 12-step activities | .34*** | .33*** | .33*** |
p <.1 [trend]
p <.05
p <.01
p <.001
Assessed at treatment end with the exception of prior treatment history and mandated status that were assessed at baseline